Investment Director
Cassie joined Parkwalk from IP Group and has worked in life sciences investment for over 10 years. Prior to joining IP Group, Cassie worked in an early-stage pharmaceutical company where she led drug development programmes from academic research into Phase II clinical studies. She has a BSc in Biochemistry and Molecular Biology and a PhD from the University of Leeds. Cassie sits of the Board of MoA Technology, Ikarovec, Pathfinder Medical, AqDot, Semarion, Qkine and Cytoseek.
